Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
10,534,093
-
Share change
-
-263,407
-
Total reported value
-
$66,648,000
-
Price per share
-
$6.32
-
Number of holders
-
23
-
Value change
-
-$1,274,711
-
Number of buys
-
13
-
Number of sells
-
10
Institutional Holders of INTEC PHARMA LTD JERUSALEM - SHS as of Q1 2018
As of 31 Mar 2018 INTEC PHARMA LTD JERUSALEM - SHS had 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,534,093 shares of stock of the company.
Largest 10 holders included ACUTA CAPITAL PARTNERS, LLC, venBio Select Advisor LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., MEITAV DASH INVESTMENTS LTD, Cormorant Asset Management, LP, Migdal Insurance & Financial Holdings Ltd., Sectoral Asset Management Inc, EDMOND DE ROTHSCHILD HOLDING S.A., CAXTON CORP, and OxFORD Asset Management LLP.
This table shows 23 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.